" class="no-js "lang="en-US"> Todd Johnson - Medtech Alert
Friday, October 24, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Todd Johnson

Todd Johnson

About Todd Johnson

Specialties: Healthcare Information Technology, Executive Leadership, Patient Engagement, Payment Reform, Physician Documentation & Charge Capture, Startup Growth, Software Design Management

Related Story

Diseases

 SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics | Pharmtech Focus

SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics

June 14 2022

SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced it has signed a […]

Artificial Intelligence

 VIDA Streamlines Respiratory Clinical Trials with Artificial Intelligence (AI) | Pharmtech Focus

VIDA Streamlines Respiratory Clinical Trials with Artificial Intelligence (AI)

November 16 2021

VIDA Diagnostics, Inc. (VIDA) is further removing friction in respiratory clinical trials with the introduction of […]

Appointments

 SomaLogic Expands Leadership Team with New Positions to Drive Commercial Success | Pharmtech Focus

SomaLogic Expands Leadership Team with New Positions to Drive Commercial Success

September 1 2021

CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI data-driven proteomics technology, […]